Back to News
investment

Where Will Centrus Energy (LEU) Stock Be in 10 Years?

newsfeedback@fool.com (Leo Sun)
Loading...
4 min read
0 likes
⚡ Quantum Brief
Centrus Energy, a U.S.-licensed uranium supplier, saw its stock surge 7,200% over the past decade after recovering from post-Fukushima nuclear energy declines and shifting to HALEU production for advanced reactors. The company pivoted from domestic LEU enrichment to importing cheaper uranium after shutting U.S. plants in 2023 and losing Russian supply deals, cutting revenue from $1.86B (2012) to $193M (2018). Revenue rebounded to $449M by 2025 (13% CAGR) as decarbonization, AI data centers, and next-gen reactors drove demand, with Centrus securing $3.8B in long-term HALEU contracts through 2040. Analysts project 5% annual revenue growth and 22% EBITDA growth through 2028, but its 9x sales valuation may cap gains, potentially leading to a 5% stock decline over the next decade. Global nuclear capacity could grow 2.6x by 2050, yet Centrus’ high valuation and limited HALEU supply expansion may constrain further stock appreciation despite industry tailwinds.
AI Audio Summary
0:00 / 0:00
Click to play
AdobeStock_1623156856_Preview.jpeg
Quantum News · Media Library

By Leo Sun – Mar 5, 2026 at 2:46PM ESTKey PointsCentrus’ stock has skyrocketed over the past ten years.But its high valuations could limit its upside potential.Centrus Energy (LEU 4.27%), one of the few U.S. companies licensed to sell low-enriched uranium (LEU), saw its stock skyrocket more than 7,200% over the past decade. Let's see why this nuclear energy stock soared -- and where it might head over the next ten years. Why did Centrus' stock soar? The Fukushima disaster in 2011 disrupted nuclear energy growth for more than a decade, as more countries paused their nuclear power projects. Those headwinds curbed the market's demand for LEU, the fuel used in most commercial nuclear reactors. Image source: Getty Images. Centrus originally enriched its own LEU on a commercial scale at its U.S. plants, but it shut down those facilities in 2023 because it became cheaper to simply import enriched uranium. That year also marked the end of the "Megatons to Megawatts" program -- a deal between the U.S. and Russia that allowed enriched weapons materials from dismantled Russian warheads to be downblended into LEU and sold to middlemen resellers like Centrus. Those changes, along with the decade-long drought in nuclear demand, reduced Centrus' revenue from $1.86 billion in 2012 to $193 million in 2018. Yet from 2018 to 2025, its revenue grew at a 13% CAGR to $449 million as several tailwinds kicked in. ExpandNYSE: LEUCentrus EnergyToday's Change(-4.27%) $-8.67Current Price$194.41Key Data PointsMarket Cap$4.0BDay's Range$187.50 - $201.9952wk Range$49.40 - $464.25Volume31KAvg Vol1.1MGross Margin23.24% The nuclear energy market stabilized as more countries launched new decarbonization initiatives, the power-hungry data center, cloud, and AI markets expanded, and more companies introduced safer, more efficient reactors to meet that demand. As the market expanded, Centrus began enriching its own high-assay, low-enriched uranium (HALEU) for advanced reactors, which it sold in limited quantities through small-scale government contracts. What will happen over the next ten years? The world's nuclear capacity could expand by up to 2.6 times from 2024 to 2050, according to the International Atomic Energy Agency (IAEA). The HALEU market should also grow much faster than the broader LEU market. At the end of 2025, Centrus had a total backlog of $3.8 billion extending through 2040. From 2025 to 2028, analysts expect its revenue and adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) to grow at CAGRs of 5% and 22%, respectively. However, its stock isn't a screaming bargain at nine times this year's sales. If Centrus matches Wall Street's estimates, grows its revenue at a 5% CAGR through 2036, but trades at a more reasonable five times sales by the final year, its stock would actually decline 5% over the next ten years. So while the nuclear market's recent expansion drove Centrus' stock higher over the past decade, it could struggle to maintain that momentum.Read NextFeb 24, 2026 •By James HiresIs Centrus Energy Stock a Buy Now -- or Is Its Potential Overhyped?Feb 12, 2026 •By Courtney CarlsenThis Nuclear Stock Could Be a Big Winner as the U.S. Rushes to Secure Its Fuel SupplyFeb 12, 2026 •By Neha ChamariaWhy Is Nuclear Energy Stock Centrus Bleeding Red?Feb 11, 2026 •By Scott LevineWhy Centrus Energy Stock Is in Free Fall TodayFeb 6, 2026 •By Neha ChamariaCentrus Energy Stock Surged 264% in 2025. What's Next?Feb 5, 2026 •By Leo SunThe Nuclear Stock Everyone's Talking About -- But Almost No One Is Pricing in Its Income PotentialAbout the AuthorLeo Sun is a contributing Motley Fool stock market analyst who has worked with the company since 2013, covering technology, consumer goods, industrial, and financial sectors. He became a self-made millionaire by age 40 through long-term investing, crediting lessons from Warren Buffett and Peter Lynch. Leo is a regular guest on CNBC Asia providing stock analysis on Chinese technology companies, including Tencent, Baidu, and Alibaba. He previously wrote for InvestorGuide and holds a bachelor’s degree in English from the University of Texas at Austin.TMFSunLionX@TMFSunLionStocks MentionedCentrus EnergyNYSE: LEU$194.28(-4.33%)-$8.80*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Read Original

Tags

energy-climate

Source Information

Source: The Motley Fool

Discussion

0 professional contributions

Sign in to join this professional discussion.

Be the first to add a constructive contribution.